Filing Details

Accession Number:
0000899243-22-036308
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-11-17 21:37:33
Reporting Period:
2022-04-01
Accepted Time:
2022-11-17 21:37:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1704292 Zai Lab Ltd ZLAB Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1835824 Harald Reinhart C/O Zai Lab Limited
314 Main Street, 4Th Floor, Suite 100
Cambridge MA 02142
See Remarks No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
American Depositary Shares Disposition 2022-04-01 246 $45.47 24,861 No 4 F Direct
American Depositary Shares Acquisiton 2022-11-15 1,854 $3.00 26,715 No 4 M Direct
American Depositary Shares Disposition 2022-11-15 1,754 $40.00 24,961 No 4 S Direct
American Depositary Shares Disposition 2022-11-15 100 $40.03 24,861 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 F Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
American Depositary Shares Stock Options (Right to Buy) Disposition 2022-11-15 1,854 $0.00 1,854 $3.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
11,480 2027-05-12 No 4 M Direct
Footnotes
  1. Each American Depositary Share (ADS) represents ten Ordinary Shares of the issuer.
  2. The shares were disposed of through a netting transaction to the issuer to cover taxes due. Due to an inadvertent administrative error, the disposition of such shares to cover taxes was not reported on the original Form 4.
  3. The reported transaction was effected pursuant to a sale plan adopted by the Reporting Person, dated 8/23/2022, expires 6/30/2023 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.